Active Immunotherapy: Could It Benefit Men at An Earlier Stage of Prostate Cancer?
In this video, Dr. Paul Schellhammer discusses recent research that suggests that active immunotherapy could be used to treat earlier stages of prostate cancer and shares his perspective about what he believes this means for men with less advanced disease. Dr. Schellhammer also explains how this research changes the landscape of treatment and what he feels are developing areas of hope for men with men with advanced and/or metastatic disease.
Experts & Guests
Paul F. Schellhammer, MD
Program Director, Virginia Prostate Center, Eastern Virginia Medical SchoolDr. Paul F. Schellhammer is the program director of the Virginia Prostate Center and professor of urology at Eastern Virginia Medical School. Dr. Schellhammer earned his undergraduate degree at the University of Notre Dame in 1962 and graduated from Cornell Medical College in 1966. He completed a surgical internship and a surgical residency at University Hospitals of Cleveland in Ohio,... more >